Bernard Poussot Elected CEO of Wyeth - - BioPharm International

ADVERTISEMENT

Bernard Poussot Elected CEO of Wyeth

BioPharm Bulletin

Wyeth (Madison, NJ) has elected Bernard Poussot president and chief executive officer (CEO), effective January 1, 2008. Poussot began his career at Wyeth in 1986. In April 2006, Poussot was promoted to president and vice chairman of Wyeth, and in January 2007, he was promoted to president, chief operating officer, and vice chairman. Robert Essner, current chairman and CEO, will continue as chairman of the board of directors after his term as CEO ends at the end of 2007.

Wyeth’s release

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014
AbbVie to Acquire Shire for $54.7 Billion
July 18, 2014
AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014
Particulate Matter Prompts Baxter's Recall of IV Solutions
July 17, 2014
Author Guidelines
Source: BioPharm Bulletin,
Click here